[5-[[1-[2-(difluoromethoxy)phenyl]piperidin-4-yl]amino]-2,4-dimethylphenyl]-[(3S)-3-(hydroxymethyl)-4-pyridin-2-ylpiperazin-1-yl]methanone

InChIKey	`CSTRZYJUXMVMTK-DEOSSOPVSA-N`
Compound Name	[5-[[1-[2-(difluoromethoxy)phenyl]piperidin-4-yl]amino]-2,4-dimethylphenyl]-[(3S)-3-(hydroxymethyl)-4-pyridin-2-ylpiperazin-1-yl]methanone
Canonical SMILES	`Cc1cc(C)c(C(=O)N2CCN(c3ccccn3)[C@H](CO)C2)cc1NC1CCN(c2ccccc2OC(F)F)CC1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	8.0
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P42345	MTOR	Homo sapiens	Human	PF02259 PF02260 PF08771 PF23593 PF11865 PF00454	8.0	IC50	ChEMBL
Q8N122	RPTOR	Homo sapiens	Human	PF02985 PF14538 PF00400	8.0	IC50	ChEMBL
Q9BVC4	MLST8	Homo sapiens	Human	PF00400	8.0	IC50	ChEMBL